Scarica l'app Stockscreener
0.6256
5.17%
-0.0341
Dopo l'orario di chiusura:
.62
-0.0056
-0.90%
Precedente Chiudi:
$0.6597
Aprire:
$0.6615
Volume 24 ore:
1.20M
Relative Volume:
1.32
Capitalizzazione di mercato:
$53.90M
Reddito:
$2.24M
Utile/perdita netta:
$-136.67M
Rapporto P/E:
-0.2732
EPS:
-2.29
Flusso di cassa netto:
$-102.08M
1 W Prestazione:
+7.71%
1M Prestazione:
+10.47%
6M Prestazione:
-30.49%
1 anno Prestazione:
-73.71%
Intervallo 1D:
$0.614
$0.6699
Intervallo di 1 settimana:
$0.5666
$0.675
Portata 52W:
$0.3418
$2.5199
Century Therapeutics Inc Stock (IPSC) Company Profile
Nome
Century Therapeutics Inc
Settore
Industria
Telefono
215-981-4000
Indirizzo
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Confronta IPSC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.6256 | 56.84M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Iniziato | Rodman & Renshaw | Buy |
| 2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-27 | Iniziato | Chardan Capital Markets | Buy |
| 2022-10-31 | Iniziato | Guggenheim | Buy |
| 2022-10-10 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-12 | Iniziato | William Blair | Mkt Perform |
| 2021-07-13 | Iniziato | BofA Securities | Buy |
| 2021-07-13 | Iniziato | JP Morgan | Overweight |
| 2021-07-13 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Century Therapeutics Inc Borsa (IPSC) Ultime notizie
What are Century Therapeutics Inc. company’s key revenue driversInvest confidently with expert support - jammulinksnews.com
Is Century Therapeutics Inc. stock overvalued or undervaluedGet daily expert analysis for smarter investing - jammulinksnews.com
How does Century Therapeutics Inc. compare to its industry peersInvest smarter with daily market updates - jammulinksnews.com
How does Century Therapeutics Inc. generate profit in a changing economyUnlock expert insights for smarter investing - jammulinksnews.com
What institutions are buying Century Therapeutics Inc. stock nowFree Stock Market Forecasting Tools - Newser
What catalysts could drive Century Therapeutics Inc. stock higher in 2025Market-leading profit generation - jammulinksnews.com
Century Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingDaily Trade Opportunity - Newser
Will Century Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Access to Group - Newser
What makes Century Therapeutics Inc. stock price move sharplyShort Term Profit Focus - Newser
What drives Century Therapeutics Inc. stock priceHigh-yield portfolio picks - PrintWeekIndia
Layoff Tracker: Adicet’s Pipeline Optimization Push Claims 30% of Workforce - BioSpace
What analysts say about Century Therapeutics Inc. stockJaw-dropping returns - PrintWeekIndia
Century Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional
Published on: 2025-07-22 15:49:56 - jammulinksnews.com
All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance
Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com
University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN
Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser
Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN
How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser
Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance
Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser
Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com
Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World
CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com
Century Therapeutics to reduce headcount by 51% - MarketScreener
Century Therapeutics Inc Azioni (IPSC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):